BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21850227)

  • 1. Noise amplification in human tumor suppression following gamma irradiation.
    Liu B; Yan S; Gao X
    PLoS One; 2011; 6(8):e22487. PubMed ID: 21850227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fourier analysis and systems identification of the p53 feedback loop.
    Geva-Zatorsky N; Dekel E; Batchelor E; Lahav G; Alon U
    Proc Natl Acad Sci U S A; 2010 Jul; 107(30):13550-5. PubMed ID: 20622152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.
    Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA
    Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oscillatory Dynamics of p53 Genetic Network Induced by Feedback Loops and Time Delays.
    Wang C; Liu H; Zhou J
    IEEE Trans Nanobioscience; 2019 Oct; 18(4):611-621. PubMed ID: 31226080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oscillations and variability in the p53 system.
    Geva-Zatorsky N; Rosenfeld N; Itzkovitz S; Milo R; Sigal A; Dekel E; Yarnitzky T; Liron Y; Polak P; Lahav G; Alon U
    Mol Syst Biol; 2006; 2():2006.0033. PubMed ID: 16773083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling the heterogeneity of p53 dynamics in DNA damage response.
    Wu W; Sun W; Sun T
    J Bioinform Comput Biol; 2016 Feb; 14(1):1650001. PubMed ID: 26493683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A truncated isoform of the PP2A B56gamma regulatory subunit reduces irradiation-induced Mdm2 phosphorylation and could contribute to metastatic melanoma cell radioresistance.
    Koma YI; Ito A; Watabe K; Kimura SH; Kitamura Y
    Histol Histopathol; 2004 Apr; 19(2):391-400. PubMed ID: 15024700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delay Hill dynamics in regulatory biological systems.
    Liu B; Yan S; Wang Q
    Mol Biosyst; 2011 Feb; 7(2):457-63. PubMed ID: 21060935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KAP1 dictates p53 response induced by chemotherapeutic agents via Mdm2 interaction.
    Okamoto K; Kitabayashi I; Taya Y
    Biochem Biophys Res Commun; 2006 Dec; 351(1):216-22. PubMed ID: 17056014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor.
    Manfredi JJ
    Genes Dev; 2010 Aug; 24(15):1580-9. PubMed ID: 20679392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mdm2 binds to Nbs1 at sites of DNA damage and regulates double strand break repair.
    Alt JR; Bouska A; Fernandez MR; Cerny RL; Xiao H; Eischen CM
    J Biol Chem; 2005 May; 280(19):18771-81. PubMed ID: 15734743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway.
    Chen CY; Oliner JD; Zhan Q; Fornace AJ; Vogelstein B; Kastan MB
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2684-8. PubMed ID: 8146175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative assessment of the p53-Mdm2 feedback loop using protein lysate microarrays.
    Ramalingam S; Honkanen P; Young L; Shimura T; Austin J; Steeg PS; Nishizuka S
    Cancer Res; 2007 Jul; 67(13):6247-52. PubMed ID: 17616682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L2DTL/CDT2 and PCNA interact with p53 and regulate p53 polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 complexes.
    Banks D; Wu M; Higa LA; Gavrilova N; Quan J; Ye T; Kobayashi R; Sun H; Zhang H
    Cell Cycle; 2006 Aug; 5(15):1719-29. PubMed ID: 16861890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles of cellular heterogeneity, intrinsic and extrinsic noise in variability of p53 oscillation.
    Wang DG; Wang S; Huang B; Liu F
    Sci Rep; 2019 Apr; 9(1):5883. PubMed ID: 30971810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
    Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
    Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells.
    Bae I; Fan S; Bhatia K; Kohn KW; Fornace AJ; O'Connor PM
    Cancer Res; 1995 Jun; 55(11):2387-93. PubMed ID: 7757991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mathematical modeling of functioning of the p53-Mdm2 protein system.
    Voropaeva OF; Shokin YI; Nepomnyashchikh LM; Senchukova SR
    Bull Exp Biol Med; 2014 Jun; 157(2):291-4. PubMed ID: 24952502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53.
    He T; Guo J; Song H; Zhu H; Di X; Min H; Wang Y; Chen G; Dai W; Ma J; Sun X; Ma J
    Pathol Oncol Res; 2018 Jan; 24(1):75-81. PubMed ID: 28341911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Explaining oscillations and variability in the p53-Mdm2 system.
    Proctor CJ; Gray DA
    BMC Syst Biol; 2008 Aug; 2():75. PubMed ID: 18706112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.